Ansell, a provider of health and safety protection solutions, has purchased a minority share of Yulex, a manufacturer of bio-based elastomer products derived from guayule.

The companies also entered into an exclusive agreement to develop, manufacture and distribute medical gloves, personal protective equipment gloves and condoms made of guayule latex.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The investment will not have any material impact on Ansell’s earnings per share in 2012 and 2013, the company said.

Guayule (parthenium argentatum) is a commercial crop that is used for latex production on a commercial scale.

Ansell CEO Magnus Nicolin said the transaction will help the company to accelerate the development of new innovative products while reducing its usage of rubber tree latex.

Yulex Corporation CEO Jeff Martin said the collaboration will accelerate the acceptance of guayule natural rubber as a US bio-based alternative for natural rubber and petroleum-based rubber products.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

”We are committed to developing ‘green’ renewable technologies for consumer and healthcare markets," Martin added.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact